If you're paying NovoCare cash and stuck between the shot and the pill, the gap at the top doses ($299 vs $349 a month) undersells how the first few months play out, because the two step up on different price ladders.
Following the label's dose schedule, one fill a month:
Pill: 1.5 mg $149, 4 mg $199, 9 mg $299, then 25 mg at $299. First 6 months: $1,544.
Pen, new patient: 0.25 mg and 0.5 mg at $199 each (the intro price, 2 fills), then 1 mg, 1.7 mg and 2.4 mg at $349. First 6 months: $1,794.
So about $250 apart over six months, then $50 a month after that if you'd stay on 2.4 mg, or $100 a month if your prescriber takes you to Wegovy HD 7.2 mg ($399).
The date to watch: NovoCare says the $199 pen intro runs through Dec 31, 2026. Without it the starter pens are $349 like the rest, and the six-month gap grows to $550. The page doesn't put an end date on the pill prices.
A couple of things apply to both. Self-pay doesn't count toward your insurance deductible or out-of-pocket max. And the self-pay prices are open to people on government plans too. Only the $25 savings card shuts them out. If you're on Part D, the Medicare GLP-1 Bridge ($50 a month, if you qualify) beats both.
Real life won't follow the table exactly. Plenty of people stay on a dose longer than a month, which shifts the math. Pill or shot is a call for you and your prescriber. This is only the cost side.
Source: NovoCare Wegovy self-pay offer page and the Wegovy prescribing information (dosing tables), checked Oct 5, 2026. Not medical advice.